Mikael Lantz (Former)
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
(
- Contribution to journal › Article
-
Mark
Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease
(
- Contribution to journal › Article
-
Mark
Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
(
- Contribution to journal › Article
- 2018
-
Mark
Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population
(
- Contribution to journal › Article
- 2017
-
Mark
Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels
(
- Contribution to journal › Article
- 2016
-
Mark
Adjuvant Treatment of Graves' Disease with Diclofenac : Safety, Effects on Ophthalmopathy and Antibody Concentrations
(
- Contribution to journal › Article
- 2015
-
Mark
PROTEOMICS OF ORBITAL TISSUE IN THYROID-ASSOCIATED ORBITOPATHY.
(
- Contribution to journal › Article
-
Mark
Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.
(
- Contribution to journal › Article
- 2014
-
Mark
ASSOCIATION OF BTG2, CYR61, ZFP36, AND SCD GENE POLYMORPHISMS WITH GRAVES' DISEASE AND OPHTHALMOPATHY.
(
- Contribution to journal › Article
-
Mark
Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
(
- Contribution to journal › Article